PI
XENE icon

Putnam Investments’s Xenon Pharmaceuticals XENE Stock Holding History

Putnam Investments’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$9.93M Buy
215,545
+43,609
+25% +$1.54M 0.01% 327
2023
Q3 		$5.87M Buy
171,936
+6,674
+4% +$250K 0.01% 405
2023
Q2 		$6.36M Buy
165,262
+11,807
+8% +$469K 0.01% 404
2023
Q1 		$5.49M Buy
153,455
+795
+0.5% +$29.4K 0.01% 427
2022
Q4 		$6.02M Buy
152,660
+23,376
+18% +$851K 0.01% 397
2022
Q3 		$4.67M Buy
+129,284
New +$4.65M 0.01% 450

Other funds holding XENE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Putnam Investments's XENE Position: Q4 2023 in Review

Putnam Investments increased its Xenon Pharmaceuticals (XENE) stake by 25% in Q4 2023, buying an estimated $1.54M and bringing the position to 215,545 shares worth $9.93M. The position accounts for 0.01% of the portfolio, ranked #327.

Putnam Investments first reported a position in XENE in Q3 2022 and has held it in 6 quarters since. 204 funds tracked by Wall St. Rank hold XENE as of Q4 2023.

  • Putnam Investments held 215,545 shares of Xenon Pharmaceuticals worth $9.93M as of Q4 2023.
  • Putnam Investments bought 43,609 Xenon Pharmaceuticals shares in Q4 2023, an estimated $1.54M.
  • Xenon Pharmaceuticals made up 0.01% of Putnam Investments's portfolio in Q4 2023, its #327 holding.
  • Putnam Investments first reported a position in Xenon Pharmaceuticals in Q3 2022 and has held it in 6 quarters since.
  • 204 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.